Literature DB >> 9673283

Heterogeneous antibody responses in tuberculosis.

K Lyashchenko1, R Colangeli, M Houde, H Al Jahdali, D Menzies, M L Gennaro.   

Abstract

Antibody responses during tuberculosis were analyzed by an enzyme-linked immunosorbent assay with a panel of 10 protein antigens of Mycobacterium tuberculosis. It was shown that serum immunoglobulin G antibodies were produced against a variety of M. tuberculosis antigens and that the vast majority of sera from tuberculosis patients contained antibodies against one or more M. tuberculosis antigens. The number and the species of serologically reactive antigens varied greatly from individual to individual. In a given serum, the level of specific antibodies also varied with the antigen irrespective of the total number of antigens recognized by that particular serum. These findings indicate that person-to-person heterogeneity of antigen recognition, rather than recognition of particular antigens, is a key attribute of the antibody response in tuberculosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9673283      PMCID: PMC108457     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

Review 1.  Serodiagnosis of parasitic diseases.

Authors:  S E Maddison
Journal:  Clin Microbiol Rev       Date:  1991-10       Impact factor: 26.132

2.  The global tuberculosis situation and the new control strategy of the World Health Organization.

Authors:  A Kochi
Journal:  Tubercle       Date:  1991-03

3.  Repertoires of antibodies to culture filtrate antigens in different mouse strains infected with Mycobacterium bovis BCG.

Authors:  K Huygen; L Ljungqvist; R ten Berg; J P Van Vooren
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

Review 4.  Immunodiagnostic assays for tuberculosis and leprosy.

Authors:  J Ivanyi; G H Bothamley; P S Jackett
Journal:  Br Med Bull       Date:  1988-07       Impact factor: 4.291

5.  Nucleotide sequence of the 19 kDa antigen gene from Mycobacterium tuberculosis.

Authors:  K R Ashbridge; R J Booth; J D Watson; R B Lathigra
Journal:  Nucleic Acids Res       Date:  1989-02-11       Impact factor: 16.971

6.  Specificity of antibodies to immunodominant mycobacterial antigens in pulmonary tuberculosis.

Authors:  P S Jackett; G H Bothamley; H V Batra; A Mistry; D B Young; J Ivanyi
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

7.  Antigens in culture supernatant of Mycobacterium tuberculosis: epitopes defined by monoclonal and human antibodies.

Authors:  A Verbon; S Kuijper; H M Jansen; P Speelman; A H Kolk
Journal:  J Gen Microbiol       Date:  1990-05

8.  Human Mycobacterium tuberculosis-reactive CD4+ T-cell clones: heterogeneity in antigen recognition, cytokine production, and cytotoxicity for mononuclear phagocytes.

Authors:  W H Boom; R S Wallis; K A Chervenak
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

9.  Heterogeneity of the repertoire of T cells of tuberculosis patients and healthy contacts to Mycobacterium tuberculosis antigens separated by high-resolution techniques.

Authors:  B Schoel; H Gulle; S H Kaufmann
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

10.  The 14,000-molecular-weight antigen of Mycobacterium tuberculosis is related to the alpha-crystallin family of low-molecular-weight heat shock proteins.

Authors:  A Verbon; R A Hartskeerl; A Schuitema; A H Kolk; D B Young; R Lathigra
Journal:  J Bacteriol       Date:  1992-02       Impact factor: 3.490

View more
  92 in total

1.  Mycobacterium tuberculosis-secreted protein antigens: immunogenicity in baboons.

Authors:  K Pehler; K M Brasky; T M Butler; R Attanasio
Journal:  J Clin Immunol       Date:  2000-07       Impact factor: 8.317

2.  The potential of recombinant antigens ESAT-6, MPT63 and mig for specific discrimination of Mycobacterium tuberculosis and M. avium infection.

Authors:  Claudia Rolinck-Werninghaus; Klaus Magdorf; Klaus Stark; Konstantin Lyashchenko; Maria Laura Gennaro; Roberto Colangeli; T Mark Doherty; Peter Andersen; Georg Plum; Udo Herz; Harald Renz; Ulrich Wahn
Journal:  Eur J Pediatr       Date:  2003-04-25       Impact factor: 3.183

3.  Antibody response to Cryptococcus neoformans proteins in rodents and humans.

Authors:  L C Chen; D L Goldman; T L Doering; L a Pirofski; A Casadevall
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

4.  Identification, molecular cloning, and evaluation of potential use of isocitrate dehydrogenase II of Mycobacterium bovis BCG in serodiagnosis of tuberculosis.

Authors:  W Florio; D Bottai; G Batoni; S Esin; M Pardini; G Maisetta; M Campa
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

5.  Effect of growth state on transcription levels of genes encoding major secreted antigens of Mycobacterium tuberculosis in the mouse lung.

Authors:  Lanbo Shi; Robert North; Maria Laura Gennaro
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

6.  Comparative evaluation of profiles of antibodies to mycobacterial capsular polysaccharides in tuberculosis patients and controls stratified by HIV status.

Authors:  Xian Yu; Rafael Prados-Rosales; Elisabeth R Jenny-Avital; Katherine Sosa; Arturo Casadevall; Jacqueline M Achkar
Journal:  Clin Vaccine Immunol       Date:  2011-12-14

7.  Immunochromatographic IgG/IgM test for rapid diagnosis of active tuberculosis.

Authors:  Walid Ben-Selma; Hedi Harizi; Jalel Boukadida
Journal:  Clin Vaccine Immunol       Date:  2011-10-12

8.  Antituberculosis IgG antibodies as a marker of active Mycobacterium tuberculosis disease.

Authors:  Ryan J Welch; Kathleen M Lawless; Christine M Litwin
Journal:  Clin Vaccine Immunol       Date:  2012-02-01

9.  Glycolipids of Mycobacterium tuberculosis strain H37Rv are potential serological markers for diagnosis of active tuberculosis.

Authors:  R P Tiwari; Dileep Tiwari; Sanjay K Garg; Ramesh Chandra; Prakash S Bisen
Journal:  Clin Diagn Lab Immunol       Date:  2005-03

Review 10.  Antibody-mediated immunity against tuberculosis: implications for vaccine development.

Authors:  Jacqueline M Achkar; Arturo Casadevall
Journal:  Cell Host Microbe       Date:  2013-03-13       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.